A Continuous Glucose Monitor Based Insulin Bolus Calculator (CGM-IBC) Study B

W

Welldoc

Status

Completed

Conditions

Diabetes Mellitus

Treatments

Device: BlueStar 10

Study type

Interventional

Funder types

Industry

Identifiers

NCT05343065
WD002

Details and patient eligibility

About

This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor.

Full description

Individuals with type 1 diabetes and those with type 2 diabetes who are prescribed bolus insulin must decide on an insulin dose for any given meal. This dose is often based on what they are eating and their glucose value. Insulin bolus calculators may be helpful in recommending an insulin dose. This study examines the safety of an app-based insulin calculator manufactured by Welldoc (Columbia, MD). This app uses the glucose value and trend arrow, in certain circumstances, to recommend a bolus insulin dose. This study is a single arm trial where continuous glucose monitoring metrics such as time in range will be measured before and after the study participants are given the app.

Enrollment

27 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 1 or type 2 diabetes using the Dexcom G6 continuous glucose monitor

Exclusion criteria

  • Pregnancy

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

27 participants in 1 patient group

CGM insulin bolus calculator arm
Experimental group
Description:
Participants will use the CGM insulin bolus calculator arm
Treatment:
Device: BlueStar 10

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems